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Introduction 
• Hypertension is one of the leading 
causes of the global burden of disease. 
 
• Approximately 7.6 million deaths 
(13–15% of the total) and 92 million 
disability-adjusted life years 
worldwide were attributable to high 
BP in 2001.  
 
• Hypertension doubles the risk of CVD:  
• coronary heart disease (CHD),  
• congestive heart failure (CHF),  
• ischemic and hemorrhagic stroke,  
• renal failure,  
• and peripheral arterial disease. 
• large segments of the hypertensive 
population are either untreated or 
inadequately treated. 
Epidemiology 
 • In the United States approximately 
30% (age-adjusted prevalence) of 
adults, or at least 65 million 
individuals, have HTN. 
 
(defined as any one of the following:  
-systolic blood pressure 140 mmHg,  
-diastolic blood pressure 90 mmHg,  
-taking antihypertensive medications).  
• The likelihood of hypertension increases 
with age, and among individuals age 60, 
the prevalence is 65.4%.  
• Obesity and weight gain are strong, 
independent risk factors for HTN.  
• It has been estimated that 60% of 
hypertensives are >20% overweight. 
• HTN prevalence is related to dietary NaCl intake, 
and the age-related increase in BP may be 
augmented by a high NaCl intake.  
• Low dietary intakes of calcium and potassium also 
may contribute to the risk of HTN.  
• The urine sodium-to-potassium ratio is a stronger 
correlate of BP than is either sodium or potassium 
alone.  
• Alcohol consumption, psychosocial stress, and low 
levels of physical activity also may contribute to 
HTN. 
• Blood pressure heritabilities are in the 
range 15–35%. 
•  In twin studies, heritability estimates of 
BP are ~60% for males and 30–40% for 
females. 
• High BP before age 55 occurs 3.8 times 
more frequently among persons with a 
positive family history of hypertension. 
Genetic Considerations 
• Although specific genetic variants 
have been identified in rare 
Mendelian forms of hypertension, 
these variants are not applicable to 
the vast majority (>98%) of patients 
with essential hypertension.  
• For most individuals, it is likely that 
hypertension represents a polygenic disorder 
in which a combination of genes acts in 
concert with environmental exposures to 
make only a modest contribution to BP.  
 
• Further, different subsets of genes may lead 
to different phenotypes associated with HTN, 
e.g., obesity, dyslipidemia, insulin resistance. 
• There may also be genetic determinants of target 
organ damage attributed to HTN.  
• Family studies indicate significant heritability of LV 
mass, and there is considerable individual 
variation in the responses of the heart to HTN.  
• Family studies and variations in candidate genes 
associated with renal damage suggest that genetic 
factors also may contribute to hypertensive 
nephropathy.  
• Specific genetic variants have been linked to CHD 
and stroke. 
Mechanisms of Hypertension 
Cardiac output and peripheral resistance are 
the two determinants of arterial pressure.  
 
Intravascular Volume 
• Sodium is predominantly an extracellular ion 
and is a primary determinant of the 
extracellular fluid volume.  
• When NaCl intake exceeds the capacity of 
the kidney to excrete sodium, vascular 
volume initially expands and cardiac output 
increases. 
• As arterial pressure increases in response 
to a high NaCl intake, urinary sodium 
excretion increases and sodium balance is 
maintained at the expense of an increase 
in arterial pressure.  
• ESRD is an extreme example of volume-
dependent hypertension. 
Autonomic Nervous System 
• The three endogenous catecholamines are 
norepinephrine, epinephrine, and dopamine.  
• All three play important roles in tonic and phasic 
cardiovascular regulation. 
• Norepinephrine and epinephrine are agonists for 
all adrenergic receptor subtypes, although with 
varying affinities.  
• Based on their physiology and pharmacology, 
adrenergic receptors have been divided into two 
principal types: α & β. 
• In both normal-weight and 
obese individuals, hypertension 
often is associated with 
increased sympathetic outflow.  
• Pheochromocytoma is the most 
blatant example of HTN related to 
increased catecholamine production, 
Renin-Angiotensin-Aldosterone Axis 
Vascular Mechanisms 
• In hypertensive patients, structural, 
mechanical, or functional changes may 
reduce the lumen diameter of small arteries 
and arterioles.  
• They have stiffer arteries, and 
arteriosclerotic patients may have 
particularly high systolic BP and wide pulse 
pressures as a consequence of decreased 
vascular compliance due to structural 
changes in the vascular wall. 
Pathologic Consequences of 
Hypertension 
• HTN is an independent predisposing factor for HF, 
CAD, stroke, renal disease, & peripheral arterial 
disease. 
• Heart 
• Brain 
• Kidney 
• Peripheral Arteries 
Defining Hypertension 
Clinical Disorders of Hypertension 
 

• Depending on methods of patient 
ascertainment, ~80–95% of patients are 
diagnosed as having "essential" HTN 
(also referred to as primary or idiopathic 
hypertension).  
• In the remaining 5–20% of patients, a 
specific underlying disorder causing the 
elevation of BP can be identified. 
Rare 
Mendelian 
Forms of 
Hypertension 
Approach to the Patient: Hypertension 
• Measurement of Blood Pressure 
• Physical exam. 
• Laboratory Testing 
Laboratory Testing 
Treatment Hypertension 
Lifestyle Interventions 
 
Pharmacologic Therapy 
• Diuretics 
• Blockers of the Renin-Angiotensin System 
• Aldosterone Antagonists 
• Beta Blockers 
• Alpha-Adrenergic Blockers 
• Sympatholytic Agents 
• Calcium Channel Blockers 
• Direct Vasodilators 
 
Hypertensive Emergencies 
